Increased Odds of Cognitive Impairment in Adults with Depressive Symptoms and Antidepressant Use

被引:0
|
作者
Meshkat, Shakila [1 ]
Wu, Michelle [2 ]
Tassone, Vanessa K. [1 ,3 ]
Janssen-Aguilar, Reinhard [1 ]
Pang, Hilary [4 ]
Jung, Hyejung [2 ]
Lou, Wendy [2 ]
Bhat, Venkat [1 ,3 ,4 ,5 ]
机构
[1] St Michaels Hosp, Intervent Psychiat Program, 193 Yonge St 6-013, Toronto, ON M5B 1M8, Canada
[2] Univ Toronto, Dalla Lana Sch Publ Hlth, Dept Biostat, Toronto, ON, Canada
[3] Univ Toronto, Inst Med Sci, Temerty Fac Med, Toronto, ON, Canada
[4] Univ Toronto, Dept Psychiat, Toronto, ON, Canada
[5] St Michaels Hosp, Neurosci Res Program, Toronto, ON, Canada
关键词
depression; cognition; cognitive impairment; NHANES; antidepressants; SEROTONIN TRANSPORTER; ALZHEIMER-DISEASE; DOUBLE-BLIND; DISORDER; METAANALYSIS; SSRIS; PERFORMANCE; DYSFUNCTION; DEMENTIA; EFFICACY;
D O I
10.1055/a-2381-2061
中图分类号
R9 [药学];
学科分类号
1007 ;
摘要
Introduction The relationship between antidepressant use and class with cognition in depression is unclear. This study aimed to evaluate the association of cognition with depressive symptoms and antidepressant use (class, duration, number). Methods Data from the National Health and Nutrition Examination Survey were examined for cognitive function through various tests and memory issues through the Medical Conditions questionnaire. Depressive symptoms were assessed using the Patient Health Questionnaire-9. Results A total of 2867 participants were included. Participants with depressive symptoms had significantly higher odds of cognitive impairment (CI) on the animal fluency test (aOR=1.89, 95% CI=1.30, 2.73, P=0.002) and Digit Symbol Substitution test (aOR=2.58, 95% CI=1.34, 4.9, P=0.007), as well as subjective memory issues (aOR=7.25, 95% CI=4.26, 12.32, P<0.001) than those without depression. There were no statistically significant associations between any of the CI categories and depressive symptoms treated with an antidepressant and antidepressant use duration. Participants who were using more than one antidepressant had significantly higher odds of subjective memory issues than those who were using one antidepressant. Specifically, users of atypical antidepressants, selective serotonin reuptake inhibitors, or tricyclic antidepressants (TCAs) had significantly higher odds of subjective memory issues in comparison to no antidepressants, with TCAs showing the largest odds (aOR=4.21, 95% CI=1.19, 14.86, P=0.028). Discussion This study highlights the relationship between depressive symptoms, antidepressant use, and CI. Future studies should further evaluate the mechanism underlying this phenomenon.
引用
收藏
页码:71 / 79
页数:9
相关论文
共 50 条
  • [21] Driving in mild cognitive impairment: The role of depressive symptoms
    Beratis, Ion N.
    Andronas, Nikos
    Kontaxopoulou, Dionysia
    Fragkiadaki, Stella
    Pavlou, Dimosthenis
    Papatriantafyllou, John
    Economou, Alexandra
    Yannis, George
    Papageorgiou, Sokratis G.
    TRAFFIC INJURY PREVENTION, 2017, 18 (05) : 470 - 476
  • [22] The Mediating Effect of Depressive Symptoms between Frailty and Cognitive Impairment in the Northeast Chinese Older Adults
    Geng, Xiaohan
    Kou, Changgui
    Wu, Songyu
    Zhang, Wangyi
    Li, Biao
    Yu, Ge
    Shen, Yuxuan
    Gao, Junling
    Li, Wenjun
    Bai, Wei
    DEMENTIA AND GERIATRIC COGNITIVE DISORDERS, 2025,
  • [23] Association of handgrip strength weakness and asymmetry with cognitive impairment and depressive symptoms in older Chinese adults
    Nazhakaiti Abudukelimu
    Peng Zhang
    Jing Du
    Min Li
    Yupei Shen
    Yanyan Mao
    Difei Wang
    Qianxi Zhu
    Scientific Reports, 15 (1)
  • [24] The Association of Anxiety and Depressive Symptoms With Cognitive Performance in Community-Dwelling Older Adults
    Beaudreau, Sherry A.
    O'Hara, Ruth
    PSYCHOLOGY AND AGING, 2009, 24 (02) : 507 - 512
  • [25] The effect of group exercises on balance, mobility, and depressive symptoms in older adults with mild cognitive impairment: a randomized controlled trial
    Langoni, Chandra da Silveira
    Resende, Thais de Lima
    Barcellos, Andressa Bombardi
    Cecchele, Betina
    da Rosa, Juliana Nunes
    Knob, Mateus Soares
    Silva, Tatiane do Nascimento
    Diogo, Tamiris de Souza
    da Silva, Irenio Gomes
    Augustin Schwanke, Carla Helena
    CLINICAL REHABILITATION, 2019, 33 (03) : 439 - 449
  • [26] SAHA Improves Depressive Symptoms, Cognitive Impairment and Oxidative Stress: Rise of a New Antidepressant Class
    Ershadi, Amir Sasan Bayani
    Amini-Khoei, Hossein
    Hosseini, Mir-Jamal
    Dehpour, Ahmad Reza
    NEUROCHEMICAL RESEARCH, 2021, 46 (05) : 1252 - 1263
  • [27] SAHA Improves Depressive Symptoms, Cognitive Impairment and Oxidative Stress: Rise of a New Antidepressant Class
    Amir Sasan Bayani Ershadi
    Hossein Amini-Khoei
    Mir-Jamal Hosseini
    Ahmad Reza Dehpour
    Neurochemical Research, 2021, 46 : 1252 - 1263
  • [28] Antidepressant Use and Cognitive Decline: The Health and Retirement Study
    Saczynski, Jane S.
    Rosen, Allison B.
    McCammon, Ryan J.
    Zivin, Kara
    Andrade, Susan E.
    Langa, Kenneth M.
    Vijan, Sandeep
    Pirraglia, Paul A.
    Briesacher, Becky A.
    AMERICAN JOURNAL OF MEDICINE, 2015, 128 (07): : 739 - 746
  • [29] Antipsychotic, antidepressant, and cognitive-impairment properties of antipsychotics: rat profile and implications for behavioral and psychological symptoms of dementia
    Kolaczkowski, Marcin
    Mierzejewski, Pawel
    Bienkowski, Przemyslaw
    Wesolowska, Anna
    Newman-Tancredi, Adrian
    NAUNYN-SCHMIEDEBERGS ARCHIVES OF PHARMACOLOGY, 2014, 387 (06) : 545 - 557
  • [30] Occurrence of Cognitive Impairment and Depressive Symptoms Among the Elderly in a Nursing Home Facility
    Kowalska, Joanna
    Rymaszewska, Joanna
    Szczepanska-Gieracha, Joanna
    ADVANCES IN CLINICAL AND EXPERIMENTAL MEDICINE, 2013, 22 (01): : 111 - 117